RejuvenAir Cryospray for Treating COPD with Chronic Bronchitis Going on Trial

The FDA has just issued a Breakthrough Device designation and an Investigational Device Exemption (IDE) to CSA Medical for its RejuvenAir system as a treatment option for patients with moderate to severe chronic obstructive pulmonary disease (COPD) ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Medicine Thoracic Surgery Source Type: blogs